About EBAMed
About Protontherapy
The foundational understanding on the use of protons for arrhythmia treatment is based on pre-clinical research performed by EBAMed’s co-founder team. Pilot clinical trials with radiotherapy demonstrated the potential increase of effectiveness of non-invasive cardiac ablation.
Proton beams have the physical characteristic of depositing most of their energy in the last few millimetres of their path. By adjusting the beam’s position and energy, the targeted 3D volume, in this case the heart, can be precisely covered, sparing surrounding healthy tissues.
For more information on protontherapy, please visit this page.
About Heart Arrythmias
Because catheter ablation is an invasive procedure, patients tend to wait longer for treatment, with a consequent drop in quality of life and aggravation of the arrythmia. In 2019, there were approximately 1.1 million catheter ablation procedures worldwide. Apart from the patient discomfort due to the surgical procedure (under partial or total anaesthesia) and the high cost due to the length (2-7 hours) and manpower required (up to 10 medical staff), the treatment effectiveness varies largely between 20%-80%.
For more information of catheter ablation for the treatment of heart arrhythmias, please visit this page.